Amgen CEO Bob Bradway detailed promising results from the company’s recent drug trial, telling CNBC’s Jim Cramer that the medicine can reduce the risk of heart...
U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss...
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen outside theri building as the company...
We are selling 300 shares of Bristol Myers Squibb at roughly $44.35. Following the trade, Jim Cramer’s Charitable Trust will own 1,100 shares of Bristol Myers,...
Drugmaker EMD Serono will reduce the cost of a common fertility medication through a deal struck with the Trump administration, President Donald Trump said Thursday while also unveiling...
